Back

Effects of hyperkalaemia and worsening renal function on pharmacotherapy in hospitalized patients with heart failure

20 May 2023 (15:00 - 16:00)
Organised by: Logo
Congress Presentation Part of: ePosters in acute heart failure 2 Clinical HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Eva Dora

General Hospital Murska Sobota, Murska Sobota (Slovenia)

7 More presentations in this session

Presentation thumbnail
Association of urine electrolytes with ultrasound markers of congestion (LUS, VExUS) and their dynamics in patients hospitalized with acute decompensated heart failure
Doctor N. Khutsishvili (Tbilisi, GE)
Abstract Slides
Presentation thumbnail
Insights from the contemporary use of levosimendan in a tertiary cardiology centre
Doctor R. Jennings (London, GB)
Abstract Slides
Presentation thumbnail
Therapeutic approach in heart failure with poor diuretic response. Peripheral ultrafiltration vs. conventional treatment
Mrs R. Lopez Vilella (Valencia, ES)
Abstract Slides
Presentation thumbnail
Development and testing of the Heart Failure Screening Questionnaire (HFQ) to support a predictive heart failure monitoring solution in patients implanted with a cardiac electronic device
Doctor S. Thompson Hilpert (Berlin, DE)
Abstract Slides
Presentation thumbnail
Differences in the profile of patients with heart failure after STEMI compared to NSTEMI
Miss R. Tomoaia (Cluj Napoca, RO)
Abstract Slides

Access the full session

Session thumbnail
ePosters in acute heart failure 2

The Event

Event poster

Heart Failure 2023

20 May 2023 15:00 CET
You may be interested in
thumbnail
Congress Presentation
In-hospital renal function variability and all-cause mortality among patients hospitalized for acute heart failure
21 May 2023
thumbnail
Webinar
How to optimise RAASi therapy in patients with hyperkalaemia
15 December 2021
thumbnail
Congress Presentation
Proportion of patients taking indapamide developing severe hypokalaemia
27 August 2021
thumbnail
Congress Presentation
Pharmacotherapy modifications in acute heart failure
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources